🇺🇸 FDA
Patent

US 11376346

Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration

granted A61KA61K35/34

Quick answer

US patent 11376346 (Extracellular matrix for treating pelvic floor disorders and skeletal muscle degeneration) held by The Regents of the University of California expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/34